PRKAA1 and chronic myelomonocytic leukemia: PRKAA1 (5′-AMP-activated protein kinase catalytic subunit alpha-1) mediates autophagy during differentiation of human monocytesis and can potentially serve as a therapeutic target in chronic myelomonocytic leukemia [64].